Jerry brings over 27 years of experience in healthcare, venture capital, and cross-border investments. Before joining LongRiver, he led over £250 million in investments as Head of Investment at TusPark Holdings UK, a Cambridge-based VC firm.
His extensive background includes leadership roles at AstraZeneca, where he drove AI and data-driven clinical research, as well as contributions to EMBL-EBI, the Wellcome Trust Sanger Institute, and the Cambridge Institute for Medical Research.
His extensive background includes leadership roles at AstraZeneca, where he drove AI and data-driven clinical research, as well as contributions to EMBL-EBI, the Wellcome Trust Sanger Institute, and the Cambridge Institute for Medical Research.
LinkedIn
